Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 16-Aug-24 4:52 PM View:  | Acrivon Therapeutics, Inc. (ACRV) | 14-Aug-24 | Payment of Exercise | 490 | $7.02 | $3,439.80 | (< 1%) 2.82M to 2.82M | |
| 16-May-24 7:02 PM View: | Acrivon Therapeutics, Inc. (ACRV) | 14-May-24 | Payment of Exercise | 490 | $8.36 | $4,096.40 | (< 1%) 2.88M to 2.88M | |
| 16-Feb-24 5:13 PM View: | Acrivon Therapeutics, Inc. (ACRV) | 14-Feb-24 | Payment of Exercise | 579 | $3.40 | $1,968.60 | (< 1%) 2.94M to 2.94M | |
| 16-Nov-23 7:42 PM View: | Acrivon Therapeutics, Inc. (ACRV) | 14-Nov-23 | Payment of Exercise | 1,900 | $5.08 | $9,652.00 | (< 1%) 2.98M to 2.98M | |
| 16-Nov-22 7:10 PM View: | Acrivon Therapeutics, Inc. (ACRV) | 14-Nov-22 | Grant | 26,707 | -- | -- | 2% 1.17M to 1.19M | |
| 16-Nov-22 7:10 PM View: | Acrivon Therapeutics, Inc. (ACRV) | 14-Nov-22 | Grant Duplicate | 1,498,240 | -- | -- | 126% 1.19M to 2.69M |